Sign Up to like & get
recommendations!
0
Published in 2017 at "Expert Review of Neurotherapeutics"
DOI: 10.1080/14737175.2017.1364993
Abstract: ABSTRACT Introduction: Oral carbamazepine (CBZ), a broad-spectrum antiseizure drug (ASD) widely used for over 50 years, remains an important treatment choice for focal (partial) epilepsy. Although CBZ is a known inducer of cytochrome P450 (CYP)…
read more here.
Keywords:
new formulation;
intravenous carbamazepine;
drug;
carbamazepine new ... See more keywords